Volition Announces Breakthrough in Enrichment of Tumor Nucleosomes

Go back to Volition Announces Breakthrough in Enrichment of Tumor Nucleosomes
VolitionRX Limited (NYSE: VNRX) Delayed: 0.35 -0.03 (7.89%)
Previous Close $0.38    52 Week High $5.86 
Open $0.37    52 Week Low $3.05 
Day High $0.37    P/E N/A 
Day Low $0.34    EPS $-0.45 
Volume 1,979,676